Interestingly, ZAG gene expression has been reported to be down-regulated in liver tissues of subjects with non-alcoholic fatty liver disease (NAFLD), and over-expression of ZAG may play a protective role against this disease [17,18]. This evidence concerns the gene AZGP1 and metabolic dysfunction-associated steatotic liver disease.